Delivery Order SPE2DB24D1104-SPE2DB24FYBT3

Award Date 8/16/24
Potential Completion Date 9/9/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of YONSA 125 MG TABLET 120S. The $4,390.96 firm fixed-price contract has a completion date of December 4, 2024. AmerisourceBergen is delivering these pharmaceutical products through an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which runs through November 2026. This IDC enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,294,927 units of the drug YONSA (125 mg tablets, 120 count). The $2,195.48 firm fixed-price contract has a period of performance through November 2024. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,195.48 firm-fixed-price contract is for the delivery of YONSA 125 MG tablets. The ultimate completion date for this contract is February 7, 2024. This order is not associated with a set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a $6,586.44 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565616978 ! YONSA 125 MG TABLET 120S. The award does not utilize a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,195.48 order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of February 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00...
This is a $8,781.92 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The order is for the delivery of 4563710352 - YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of March 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, under a firm-fixed-price contract with a ceiling value of $2,195.48. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a potential value of $8,781.92 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication YONSA 125 MG TABLET 120S. The contract, valued at $4,390.96, has a period of performance through May 28, 2024 and is a firm-fixed-price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of December 11, 2024. It is not designated as a set-aside contract, indicating open competition....
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYBT3
    Delivery Order

This is a $2,195.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product YONSA 125 MG TABLET 120S. The contract has a period of performance through September 9, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide.

Generated 11/15/24, 9:25 AM